Medtronic v. Boston Scientific: Appeals Court Affirms Taxus Non-Infringement
This article was originally published in The Gray Sheet
Boston Scientific's Taxus, Express and NIR stents do not infringe four Medtronic stent design patents, the U.S. Court of Appeals for the Federal Circuit affirms in a May 26 ruling
You may also be interested in...
Medtronic will appeal a Delaware federal court patent infringement ruling against its Driver and S7 coronary stents and challenge the validity of Guidant's Lau patent, the firm says
As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.
In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.